This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Topic Collections  • Viral Infections  • Neurology  • Neuromuscular diseases  • Immunization  • World Health  • Infectious Diseases  • Alert me on articles by topic  Social Bookmarking   What's this?

JAMA. 2006;295:155-156.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

MMWR. 2005;54:1186-1188

1 table omitted

The second meeting of the Advisory Committee on Poliomyelitis Eradication (ACPE) was convened in Geneva, Switzerland, on October 11-12, 2005, to provide the World Health Organization (WHO) and the Global Polio Eradication Initiative with advice on program policies for (1) interrupting wild poliovirus (WPV) transmission worldwide, (2) limiting the international spread of circulating polioviruses, and (3) refining the program of work for eventual cessation of immunization with oral poliovirus vaccine (OPV). This report summarizes the results of that meeting.*

Interrupting WPV Transmission

As of October 25, 2005, paralytic polio cases attributed to WPV had been reported from 16 countries, including five of the six countries that were endemic for indigenous WPV during 2004. In the disease-endemic reservoirs in India and Pakistan, transmission had been reduced by 50%, compared with the same period in 2004.

The development, licensure, and use of monovalent OPV type 1 (mOPV1) appears to have . . . [Full Text of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?